KPF
OACC

K2 Principal Fund’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

K2 Principal Fund’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Buy
365,900
+170,608
+87% +$1.82M 0.29% 109
2026
Q1 		$2.07M Hold
195,292
– – 0.14% 170
2025
Q4 		$2.07M Hold
195,292
– – 0.17% 158
2025
Q3 		$2.05M Hold
195,292
– – 0.17% 153
2025
Q2 		$2.04M Hold
195,292
– – 0.28% 107
2025
Q1 		$2M Hold
195,292
– – 0.25% 110
2024
Q4 		$1.95M Buy
+195,292
New +$1.95M 0.22% 112

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

K2 Principal Fund's OACC Position: Q2 2026 in Review

K2 Principal Fund increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 87% in Q2 2026, buying an estimated $1.82M and bringing the position to 365,900 shares worth $3.92M. The position accounts for 0.29% of the portfolio, ranked #109.

K2 Principal Fund first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. 50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • K2 Principal Fund held 365,900 shares of Oaktree Acquisition Corp III Life Sciences worth $3.92M as of Q2 2026.
  • K2 Principal Fund bought 170,608 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $1.82M.
  • Oaktree Acquisition Corp III Life Sciences made up 0.29% of K2 Principal Fund's portfolio in Q2 2026, its #109 holding.
  • K2 Principal Fund first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on K2 Principal Fund's 13F filing for Q2 2026, filed 7 Aug 2026.